As the sector waits for the 7CPA to be signed, GPs have complained about pharmacy and flu jabs, one stakeholder called for ‘sweeping change’ to pharmacy and there are new …

Italy is one of the nations that has been most impacted by the COVID-19 pandemic. New data shows just how it has affected community pharmacists    Since the beginning of …

Angelo Pricolo examines a more relaxed way to look at life… and the importance of flexibility On a recent holiday to Italy, for the first time with wife and kids, …

Business is far from booming in pharmacy, as economic fallout from the COVID-19 pandemic has readers worried about job security and business viability Earlier this month, the AJP asked readers …

New restrictions on opioids provide an excellent opportunity for pharmacists to raise awareness about dependence, naloxone and pain management, say stakeholders Commencing Monday, 1 June 2020, the PBS listings for …

What’s the best way to support your pharmacy team during the pandemic? A recent webinar from AJP and PSS provides some valuable advice This week AJP and the Pharmacists’ Support …

The TGA has reminded advertisers not to produce ads that undermine public health campaigns, such as advice to stay home when sick As the cold and flu season begins in …

The prevalence of gout is increasing in Australia, and pharmacists have a key role to play in its treatment and management, writes Brad Butt When one thinks about gout they …

Location rules, ownership rules and funding model changes should be considered in the post-pandemic landscape, expert says  Sweeping changes should be considered to the way primary care operates and is …

A new coalition of stakeholders are calling for improved access to early medical abortion – and in the time of COVID-19, it’s more important than ever, says one member To …

The PSA is launching a support line to help members of the profession deal with electronic scripts Over 10 million telehealth consultations between Australians and their health care providers have …

They admitted to making false or misleading representations in the marketing of two pain relief products GlaxoSmithKline Consumer Healthcare Australia and Novartis Consumer Health Australasia have been ordered to pay …